BeiGene Investor Relations Material
Latest events
Q1 2025
BeiGene
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BeiGene Ltd
Access all reports
BeiGene Ltd. is a biotechnology company focused on the discovery, development, and commercialization of innovative oncology treatments. Established in 2010, BeiGene has expanded its operations globally, with a significant presence in markets including the United States, China, Europe, and Australia. The company's product portfolio includes a range of treatments targeting various cancers such as blood cancers, solid tumors, and myelodysplastic syndromes. BeiGene is also actively involved in collaborative projects with other pharmaceutical companies to enhance its research and development capabilities. The company is headquartered in Grand Cayman, Cayman Islands, and its shares are listed on the NASDAQ.
Key slides for BeiGene Ltd
Goldman Sachs 45th Annual Global Healthcare Conference
BeiGene Ltd
Q4 2024
BeiGene Ltd
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
BGNE
Country
🇺🇸 United States